Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $76.49 | 6 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $65.50 | 5 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $10.99 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $26.69 | 2 | GlaxoSmithKline, LLC. ($26.69) |
| 2022 | $26.24 | 2 | GlaxoSmithKline, LLC. ($26.24) |
| 2020 | $10.99 | 1 | AstraZeneca Pharmaceuticals LP ($10.99) |
| 2018 | $12.57 | 1 | GlaxoSmithKline, LLC. ($12.57) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/08/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: RESPIRATORY | ||||||
| 01/31/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: RESPIRATORY | ||||||
| 11/29/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: RESPIRATORY | ||||||
| 07/27/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: RESPIRATORY | ||||||
| 04/08/2020 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $10.99 | General |
| Category: Respiratory | ||||||
| 11/14/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.57 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 388 | 507 | $89,372 | $24,966 |
| 2022 | 19 | 1,214 | 1,951 | $332,853 | $112,120 |
| 2021 | 18 | 1,101 | 1,807 | $309,461 | $114,860 |
| 2020 | 19 | 1,398 | 2,544 | $289,919 | $104,972 |
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 235 | 335 | $58,960 | $15,008 | 25.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 58 | 71 | $18,460 | $5,793 | 31.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 28 | 28 | $10,248 | $3,573 | 34.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 38 | 44 | $396.00 | $369.60 | 93.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 17 | 17 | $816.00 | $119.85 | 14.7% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2023 | 12 | 12 | $492.00 | $102.63 | 20.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 331 | 796 | $140,096 | $47,036 | 33.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 146 | 237 | $61,620 | $20,673 | 33.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 133 | 133 | $48,678 | $17,462 | 35.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 109 | 112 | $20,496 | $7,841 | 38.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 25 | 25 | $13,625 | $4,208 | 30.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 34 | 34 | $13,600 | $4,018 | 29.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 119 | 122 | $10,004 | $3,584 | 35.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 11 | 12 | $7,056 | $2,679 | 38.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 13 | 62 | $3,224 | $970.04 | 30.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 16 | 17 | $1,819 | $730.40 | 40.2% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 36 | 36 | $2,160 | $663.52 | 30.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 67 | 69 | $3,312 | $552.46 | 16.7% |
| 85610 | Blood test, clotting time | Office | 2022 | 13 | 101 | $1,717 | $426.88 | 24.9% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2022 | 32 | 32 | $1,312 | $297.75 | 22.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 55 | 80 | $720.00 | $236.01 | 32.8% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 30 | 30 | $810.00 | $214.47 | 26.5% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 11 | 11 | $649.00 | $210.90 | 32.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 16 | 19 | $1,311 | $173.15 | 13.2% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2022 | 17 | 23 | $644.00 | $144.26 | 22.4% |
About Dr. Michele Ballou, MD
Dr. Michele Ballou, MD is a Pulmonary Disease healthcare provider based in Low Moor, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1730184789.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michele Ballou, MD has received a total of $76.49 in payments from pharmaceutical and medical device companies, with $26.69 received in 2023. These payments were reported across 6 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($76.49).
As a Medicare-enrolled provider, Ballou has provided services to 4,101 Medicare beneficiaries, totaling 6,809 services with total Medicare billing of $356,918. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Practice Information
- Specialty Pulmonary Disease
- Location Low Moor, VA
- Active Since 06/16/2005
- Last Updated 02/08/2019
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1730184789
Products in Payments
- TRELEGY ELLIPTA (Drug) $65.50
- SYMBICORT (Drug) $10.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.